Expertise that unites real-world evidence and patient access to improve outcomes.
UBC brings together seasoned professionals specializing in specialty therapies across risk management, evidence development, and patient access. Providing collaborative, expert-driven solutions tailored to your program, we are driven by a commitment to overcoming the barriers between your therapy and the patients that need it most. We leverage unrivaled expertise, real-world data and the latest technologies to provide the insights you need to mitigate risk, demonstrate long-term product value, ensure access, and support better patient outcomes.tis, pulvinar dapibus leo.
Insights
Interview with Josh Hardman of Psychedelic Alpha
UBC talked with Josh Hardman, founder of Psychedelic Alpha, to discuss the evolving landscape of psychedelic drug development—from shifting regulatory expectations to the role of psychotherapy and the impact of stigma on patient access. Hardman shares a clear-eyed perspective on where the field stands today, the scientific rigor needed to advance it, and what he’s watching most closely as the industry moves toward potential first approvals.
News
UBC Acquires Evidinno Outcomes Research, Expanding Real-World Evidence and HEOR Capabilities
United BioSource LLC (UBC) has acquired Evidinno Outcomes Research Inc., a Vancouver-based healthcare research consulting firm specializing in real-world evidence (RWE), epidemiology, evidence synthesis, and advanced statistical and economic analysis.
Events
World Orphan Drug Congress 2026
UBC is proud to participate in the World Orphan Drug Congress USA, the premier event dedicated to rare disease therapies and orphan drug development. Connect with our experts to learn how we deliver integrated solutions for evidence generation, risk management, and patient access—helping sponsors navigate complex programs and ensure patient-centric outcomes.
A Better Start to Therapy
With streamlined enrollment options and real-time capabilities, including purpose-built patient access technology solutions, UBC brings a “no patient left behind” approach to the start of therapy.
A Better Start to Therapy
With streamlined enrollment options and real-time capabilities, including purpose-built patient access technology solutions, UBC brings a “no patient left behind” approach to the start of therapy.
A Better Start to Therapy
With streamlined enrollment options and real-time capabilities, including purpose-built patient access technology solutions, UBC brings a “no patient left behind” approach to the start of therapy.
A Better Start to Therapy
With streamlined enrollment options and real-time capabilities, including purpose-built patient access technology solutions, UBC brings a “no patient left behind” approach to the start of therapy.
A Better Start to Therapy
With streamlined enrollment options and real-time capabilities, including purpose-built patient access technology solutions, UBC brings a “no patient left behind” approach to the start of therapy.
A Better Start to Therapy
With streamlined enrollment options and real-time capabilities, including purpose-built patient access technology solutions, UBC brings a “no patient left behind” approach to the start of therapy.
A Better Start to Therapy
With streamlined enrollment options and real-time capabilities, including purpose-built patient access technology solutions, UBC brings a “no patient left behind” approach to the start of therapy.
